ScreenerHero

SGPSpyGlass Pharma Inc. Common Stock

NAS · US · Healthcare · Biotechnology · spyglasspharma.com
26.51USD-2.64%Mkt Cap: 886.71M $P/E: —

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL S…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap886.71M $
Enterprise Value644.79M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.87M $
Revenue/Share—
Last Price26.51 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.66
PEG—
EV/EBITDA-10.55
EV/Revenue—
P/S—
P/B3.51
EPS (TTM)-1.62
EPS (Forward)-2.72
52W Range
17.0661% of range32.44
52W High32.44 USD
52W Low17.06 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE40.34%
ROA-34.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.70M $
CapEx (TTM)789.00K $
FCF Margin—
FCF Yield—
Net Debt-232.55M $
Net Debt/EBITDA3.81
Balance Sheet
Debt/Equity-0.02
Current Ratio25.06
Quick Ratio24.89
Book Value/Sh7.481 USD
Cash/Share7.001 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.00 USD
Upside (mean)+66.0%
Target Range37.00 USD – 62.00 USD
$37.00+66.0% to mean$62.00
# Analysts6
Ownership
Shares Out.33.45M
Float6.50M
Insiders4.28%
Institutions94.67%
Short Interest
Short Ratio9.8d
Short % Float10.27%
Short % Out.3.41%
Shares Short1.14M
Short (prev mo.)1.31M
Technical
SMA 5021.51 (+23.2%)
SMA 20023.30 (+13.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)97.89K
Avg Vol (10d)71.95K
Technical Indicators
RSI (14)66.2
MACD1.4379
MACD Signal1.3258
MACD Hist.+0.1121
BB Upper28.05 USD
BB Middle24.42 USD
BB Lower20.78 USD
BB Width29.76%
ATR (14)1.438 USD
Vol Ratio (20d)0.68x